Local TXA Reduces Blood Loss vs Intravenous TXA in Patients Undergoing Total Hip Replacement
How to Cite
OrthoEvidence. Local TXA Reduces Blood Loss vs Intravenous TXA in Patients Undergoing Total Hip Replacement . ACE Report. 2020;9(12):4. Available from: https://myorthoevidene.com/AceReport/Report/12649
Better Treatment Values in Local Application of Tranexamic Acid (TXA) than Intravenous Application with the Same Dose in Total Hip Arthroplasty.Adv Ther. 2020 Oct;37(10):4346-4355.
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Seventy-two patients scheduled for a primary, unilateral total hip replacement were randomized to receive a local administration of tranexamic acid (TXA) or intravenous administration of TXA at the same dosage. Outcomes of interest included the following: total blood loss, hidden blood loss, incidence of blood transfusion, hematocrit (Hct) and hemoglobin (Hb) levels, C-reactive protein (CRP) and i...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE